Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,109 | -63,937 | -50,074 | -34,657 | -21,911 |
| Depreciation Amortization | 7,138 | 2,885 | 2,370 | 3,184 | 1,290 |
| Income taxes - deferred | -35,679 | 982 | 33,337 | -1,702 | N/A |
| Accounts payable and accrued liabilities | 1,592 | 3,714 | -2,713 | -497 | 878 |
| Other Working Capital | -17,438 | 25,506 | 14,802 | -222 | 438 |
| Other Operating Activity | -65,902 | -40,078 | -39,791 | 5,130 | 2,816 |
| Operating Cash Flow | $-99,180 | $-70,928 | $-42,069 | $-28,764 | $-16,489 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -6,750 | N/A | N/A | N/A |
| PPE Investments | -10,972 | -6,860 | -3,707 | -591 | -420 |
| Net Acquisitions | -5,557 | -3,842 | 27,759 | N/A | 428 |
| Purchase Of Investment | N/A | N/A | -11,500 | -10,000 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -511 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -511 |
| Investing Cash Flow | $-16,529 | $-17,452 | $12,552 | $-10,591 | $-503 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49,916 | 48,320 | -3,095 | 7,500 | 6,850 |
| Debt Repayment | -53,157 | -9,451 | N/A | N/A | N/A |
| Common Stock Issued | 57,928 | 108,510 | 1,699 | 72,090 | 37,718 |
| Common Stock Repurchased | N/A | -15,639 | N/A | N/A | N/A |
| Other Financing Activity | -1,012 | 0 | -1,951 | 0 | -1,000 |
| Financing Cash Flow | $53,675 | $131,740 | $-3,347 | $79,590 | $43,568 |
| Exchange Rate Effect | 65 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 82,398 | 39,038 | 71,902 | 31,667 | 5,091 |
| End Cash Position | 20,429 | 82,398 | 39,038 | 71,902 | 31,667 |
| Net Cash Flow | $-61,969 | $43,360 | $-32,864 | $40,235 | $26,576 |
| Free Cash Flow | |||||
| Operating Cash Flow | -99,180 | -70,928 | -42,069 | -28,764 | -16,489 |
| Capital Expenditure | -10,972 | -6,860 | -3,707 | -591 | -420 |
| Free Cash Flow | -110,152 | -77,788 | -45,776 | -29,355 | -16,909 |